ライフサイエンスコーパス: thoracic duct

1 for visualization of the thoracic duct ( TD thoracic duct ).

2 f trunk lymphatic vessels and did not form a thoracic duct.

3 l circuits connecting to lymph nodes and the thoracic duct.

4 mph nodes and traffic into the blood via the thoracic duct.

5 from lymphoid tissues into blood, the human thoracic duct.

6 vessels and large lymphatic trunks like the thoracic duct.

7 formation of the PAC and, subsequently, the thoracic duct.

8 bsequently heal, permitting DCs to enter the thoracic duct.

9 ump in both mesenteric lymphatics and in the thoracic duct.

10 al effusions, ascites, and dilatation of the thoracic duct.

11 pumping capacity and morphologically changed thoracic duct.

12 muscle myosin heavy chain (SM-MHC), whereas thoracic duct and arterioles expressed both SMA and SMB

13 le activities and MLC(20) phosphorylation of thoracic duct and cervical lymphatics were determined in

14 e collecting lymphatic vessels including the thoracic duct and cisterna chyli, and presenting as chyl

15 atic contractions in isolated human vessels (thoracic duct and mesenteric lymphatics) maintained unde

16 and their messages in mesenteric lymphatics, thoracic duct, and arterioles.

17 pment of the lymphatic system, including the thoracic duct, and that alpha9 deficiency could be one c

18 The active pump of the thoracic duct appeared more sensitive to flow than did t

19 ults show lymphatic endothelial cells of the thoracic duct arise from primitive veins through a novel

20 n is transiently expressed in the developing thoracic duct at embryonic day 14, but expression is rap

21 it completely stopped phasic contractions of thoracic duct at that concentration.

22 External drainage of the thoracic duct can temporarily reduce tissue congestion a

23 ting intestinal lymph DCs were collected via thoracic duct cannulation from B27-transgenic and contro

24 Intranodal lymphangiogram and thoracic duct catheterization was successful in all pati

25 ML-7 treatment of the thoracic duct caused a significant decrease in both the

26 of tension were both significantly higher in thoracic duct compared to cervical lymphatics.

27 ing of PKG-Ialpha protein in the wall of rat thoracic duct confirmed its localization inside TD muscl

28 A technique for transcatheter thoracic duct decompression (TDD), rerouting the thoraci

29 all models used in vivo (3 murine models and thoracic duct development in zebrafish) and in vitro (ly

30 t both Cx37 and Cx43 are required for normal thoracic duct development, including valve formation.

31 igher frequency of LALM (29% vs 9%, P<.001), thoracic duct dilatation (4% vs 0, P=.3), pleural effusi

32 mmon in TSC/LAM, while lymphatic involvement-thoracic duct dilatation, chylous pleural effusion, asci

33 lcified pulmonary nodules, pleural effusion, thoracic duct dilatation, hepatic and renal angiomyolipo

34 letion: batch plasmapheresis (BP; n = 5) and thoracic duct drainage (TD; n = 5).

35 re, we report on our initial experience with thoracic duct drainage and autotransfusion in patients w

36 rds of 8 patients who underwent percutaneous thoracic duct drainage with autotransfusion as part of t

37 Thoracic duct drainage with autotransfusion can improve

38 In this study, the thoracic duct exhibited significant functional differenc

39 These data indicate that thoracic duct has an enhanced sensitivity to MLCK inhibi

40 gulatory mechanism that maintains pumping in thoracic duct in an energy-saving/efficient mode: it imp

41 ed ascites in eight (10%), dilatation of the thoracic duct in seven (9%), and hepatic AML in three (4

42 s of the neck or chest wall can be caused by thoracic duct injury.

43 sults from retrograde flow of chyle from the thoracic duct into lymphatic tributaries with defective

44 Although retrograde flow of chyle from the thoracic duct is considered a potential mechanism underl

45 phatic network in the zebrafish, whereas the thoracic duct is initially dispensable for lymphatic fun

46 Less-invasive surgical procedures such as thoracic duct ligation by video-assisted thoracoscopy ar

47 Thoracic duct ligation has been reported as a highly suc

48 to characterize tissue-emigrant lineages in thoracic duct lymph (TDL).

49 D-1-bright (CXCR5BrPD-1Br) Tfh population in thoracic duct lymph (TDL).

50 se agonists produce lymphopenia in blood and thoracic duct lymph by sequestration of lymphocytes in l

51 ed in the intestinal (afferent) and efferent thoracic duct lymph of rats during the course (0 to 289

52 rough the gut (mesenteric efferent and lower thoracic duct lymph).

53 In thoracic duct lymph, cells that could prevent diabetes w

54 e and was transported to the circulation via thoracic duct lymph.

55 er tone at a given pressure when compared to thoracic duct lymphatics.

56 y analyzed the TCR Vbeta repertoires of CD4+ thoracic duct lymphocytes (TDL) collected during the ini

57 positively selected miHA-specific donor CD8+ thoracic duct lymphocytes (TDL) collected from irradiate

58 y almost 100-fold as measured by enumerating thoracic duct lymphocytes (TDL) obtained early post-tran

59 alloreactive T cell expansion and function, thoracic duct lymphocytes (TDL) were analyzed.

60 To determine how RAPA inhibited GVHD, thoracic duct lymphocytes (TDL) were isolated from recip

61 Fewer CD4+ thoracic duct lymphocytes (TDL) were obtained in mAb-tre

62 perimental data on migration of 51Cr-labeled thoracic duct lymphocytes (TDLs) via major lymphoid and

63 d functional analysis of positively selected thoracic duct lymphocytes 4 days after transplant and by

64 e, systems view of recirculation kinetics of thoracic duct lymphocytes in the whole organism.

65 In thoracic duct MLC(20) di-phosphorylation, but not mono-p

66 rgrowth of the jugular lymph sacs/primordial thoracic ducts, oedema and embryonic lethality.

67 luorescent tracer revealed that lymph in the thoracic duct of these mice could enter the thoracic cav

68 ntestinal lymph was collected by cannulating thoracic ducts of mesenteric lymphadenectomized animals.

69 agent through the lymphatic system to the TD thoracic duct outlet was 244 seconds (range, 201-387 sec

70 However, in thoracic duct, predominantly cardiac alpha-actin and vas

71 nsible for the self-regulatory adjustment of thoracic duct pumping to changes in lymph flow pattern.

72 ACNA1C were consistently detected from human thoracic duct samples examined and the CaV1.2 protein wa

73 either lymphatic embolization procedures or thoracic duct stenting with covered stents to exclude re

74 imaging specialist for visualization of the thoracic duct ( TD thoracic duct ).

75 : 2 patients (8%) with traumatic leak from a thoracic duct (TD) branch, 14 patients (56%) with pulmon

76 of the lymphatic network with blood from the thoracic duct (TD) in both neonatal and mature mice.

77 We show that mouse thoracic duct (TD) lymph contains HSPCs that possess sho

78 dependent regulation of contractility in rat thoracic duct (TD).

79 quantification of lymphatic flow rate in the thoracic duct (TD).

80 acic duct decompression (TDD), rerouting the thoracic duct to the pulmonary venous atrium to treat mu

81 onstrated retrograde lymphatic flow from the thoracic duct toward lung parenchyma.

82 Enhancement was seen in the TD thoracic duct up to 1 hour after injection.

83 The thoracic duct was elongated 10% ( P=0.0409) and with an

84 In contrast, the TD thoracic duct was visualized in all five of the animals

85 The TD thoracic duct was visualized in three of the five animal

86 Lymphatic segments of the rat thoracic duct were isolated, cannulated and pressurized.

87 roperitoneal lymphatics, cisterna chyli, and thoracic duct were viewed with an accuracy of 23 of 25 (

88 Rat mesenteric lymphatics and thoracic ducts were isolated, cannulated and pressurized

89 both the active peak and plateau tensions of thoracic duct, whereas only the active peak tension of c

90 phatic contraction, we hypothesized that the thoracic duct would be more sensitive to the modulation